BRUCE WISHNOV: Open Payments
NPI 1134296395 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$897 in 39 payments from 15 companies in 2025. Trend: 2023 $817 · 2024 $750 · 2025 $897
Food & beverage: $897
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $154 |
| Lundbeck LLC | 3 | $92 |
| Amgen Inc. | 5 | $91 |
| Lilly USA, LLC | 4 | $81 |
| Novo Nordisk Inc | 3 | $67 |
| ABBVIE INC. | 3 | $64 |
| Otsuka America Pharmaceutical, Inc. | 2 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Exact Sciences Corporation | 2 | $57 |
| Astellas Pharma US Inc | 2 | $44 |
Products named: XIFAXAN, REXULTI, CAPLYTA, Cologuard Collection Kit, Wegovy, Veozah, MOUNJARO, EVENITY.
Industry payments across FL — which companies pay providers there.
